Literature DB >> 8589448

Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells.

Y Ishizaki1, L Cheng, A W Mudge, M C Raff.   

Abstract

We recently proposed that most mammalian cells constitutively express all of the proteins required to undergo programmed cell death (PCD) and undergo PCD unless continuously signaled by other cells not to. Although some cells have been shown to work this way, the vast majority of cell types remain to be tested. Here we tested purified fibroblasts isolated from developing or adult rat sciatic nerve, a mixture of cell types isolated from normal or p53-null mouse embryos, an immortalized rat fibroblast cell line, and a number of cancer cell lines. We found the following: 1) All of these cells undergo PCD when cultured at low cell density in the absence of serum and exogenous signaling molecules but can be rescued by serum or specific growth factors, suggesting that they need extracellular signals to avoid PCD. (2) The mixed cell types dissociated from normal mouse embryos can only support one another's survival in culture if they are in aggregates, suggesting that cell survival in embryos may depend on short-range signals. (3) Some cancer cells secrete factors that support their own survival. (4) The survival requirements of a human leukemia cell line change when the cells differentiate. (5) All of the cells studied can undergo PCD in the presence of cycloheximide, suggesting that they constitutively express all of the protein components required to execute the death program.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589448      PMCID: PMC301303          DOI: 10.1091/mbc.6.11.1443

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  50 in total

Review 1.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

Review 2.  Insulin-like growth factors and their binding proteins.

Authors:  V R Sara; K Hall
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

3.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant.

Authors:  J G Flanagan; D C Chan; P Leder
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

4.  Catecholamines in peripheral tissues of mice and cell counts of sympathetic ganglia after the prenatal and postnatal administration of the nerve growth factor antiserum.

Authors:  G I Klingman; J D Klingman
Journal:  Int J Neuropharmacol       Date:  1967-11

Review 5.  Neurotrophic factors. Switching neurotrophin dependence.

Authors:  A M Davies
Journal:  Curr Biol       Date:  1994-03-01       Impact factor: 10.834

Review 6.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

7.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels.

Authors:  P D Benya; J D Shaffer
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

Review 8.  A comparison of the biological activities of wild-type and mutant p53.

Authors:  G P Zambetti; A J Levine
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

9.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

10.  1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.

Authors:  D J Mangelsdorf; H P Koeffler; C A Donaldson; J W Pike; M R Haussler
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

View more
  22 in total

1.  The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.

Authors:  M Le Gall; J C Chambard; J P Breittmayer; D Grall; J Pouysségur; E Van Obberghen-Schilling
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

Review 2.  Mitochondria and apoptosis: HQ or high-security prison?

Authors:  N J Waterhouse; D R Green
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  v-Src generates a p53-independent apoptotic signal.

Authors:  B L Webb; E Jimenez; G S Martin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.

Authors:  M D Jacobsen; M Weil; M C Raff
Journal:  J Cell Biol       Date:  1996-06       Impact factor: 10.539

5.  The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts.

Authors:  G M Fimia; V Gottifredi; B Bellei; M R Ricciardi; A Tafuri; P Amati; R Maione
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

6.  Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis.

Authors:  C Koumenis; A Giaccia
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

7.  CD44-positive cells are candidates for astrocyte precursor cells in developing mouse cerebellum.

Authors:  Na Cai; Masashi Kurachi; Koji Shibasaki; Takayuki Okano-Uchida; Yasuki Ishizaki
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

8.  Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family.

Authors:  D Jean; M Bar-Eli
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 9.  Kinase cascades regulating entry into apoptosis.

Authors:  P Anderson
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

10.  Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.

Authors:  Ramarao Malla; Sreelatha Gopinath; Kiranmai Alapati; Christopher S Gondi; Meena Gujrati; Dzung H Dinh; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.